Tuesday, 10 May 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Trump's Team Wanted To Ban Voting Machines In Half Of US Last Year: Report

White House adviser Kurt Olsen, a lawyer Trump has tasked with proving widely debunked election-rigging conspiracy theories, pushed the plan...